Bristol Myers Squibb reported $100.36B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
ALKERMES ALKS:US $ 1957.42M 20.43M
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 96579M 3694M
Astrazeneca AZN:US $ 96579M 3694M
Biogen BIIB:US $ 25081.4M 1467M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Catalent CTLT:US $ 10322M 119M
Coherus Biosciences CHRS:US $ 546M 47.38M
Endo International Ordinary Shares ENDP:US $ 8447.21M 320.2M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 89045M 644M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 572.31M 22.63M
Medtronic MDT:US $ 90981M 823M
Novartis NOVN:VX SF 122910M 2308M
Perrigo Ordinary Shares PRGO:US $ 10389.5M 36.2M
Phibro Animal Health PAHC:US $ 916.18M 67.22M
Prestige Brands PBH:US $ 3682.23M 11.55M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Revance Therapeutics RVNC:US $ 639.55M 108.38M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
United Therapeutics UTHR:US $ 5543.3M 183.5M